Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

SURMOUNT-OSA

Eli Lilly · Phase 3 · Completed · Enrollment 469

NCT05412004

EudraCT 2021-004552-41

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Tirzepatide MTD_GPI129 participants20 participants30 participantsn/r0
Placebo_GPI112 participants5 participants15 participantsn/r0
Tirzepatide MTD_GPI226 participants11 participants26 participantsn/r0
Placebo_GPI26 participants1 participants10 participantsn/r0

A count stays a count. This page does not turn a count into a percent.